Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B
Identifieur interne : 000181 ( France/Analysis ); précédent : 000180; suivant : 000182Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B
Auteurs : Aziz Alami Chentoufi [États-Unis] ; Nicholas R. Binder [États-Unis] ; Noureddine Berka [Canada] ; Guillaume Durand [France] ; Alex Nguyen [États-Unis] ; Ilham Bettahi [États-Unis] ; Bernard Maillere [France] ; Lbachir Benmohamed [États-Unis]Source :
- Journal of virology [ 0022-538X ] ; 2008.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Abstract
The identification of "asymptomatic" (i.e., protective) epitopes recognized by T cells from herpes simplex virus (HSV)-seropositive healthy individuals is a prerequisite for an effective vaccine. Using the PepScan epitope mapping strategy, a library of 179 potential peptide epitopes (15-mers overlapping by 10 amino acids) was identified from HSV type 1 (HSV-1) glycoprotein B (gB), an antigen that induces protective immunity in both animal models and humans. Eighteen groups (G1 to G18) of 10 adjacent peptides each were first screened for T-cell antigenicity in 38 HSV-1-seropositive but HSV-2-seronegative individuals. Individual peptides within the two immunodominant groups (i.e., G4 and G14) were further screened with T cells from HLA-DR-genotyped and clinically defined symptomatic (n = 10) and asymptomatic (n = 10) HSV-1-seropositive healthy individuals. Peptides gB161-175 and gB166-180 within G4 and gB661-675 within G14 recalled the strongest HLA-DR-dependent CD4+ T-cell proliferation and gamma interferon production. gB166-180, gB661-675, and gB666-680 elicited ex vivo CD4+ cytotoxic T cells (CTLs) that lysed autologous HSV-1- and vaccinia virus (expressing gB)-infected lymphoblastoid cell lines. Interestingly, gB166-180 and gB666-680 peptide epitopes were strongly recognized by CD4+ T cells from 10 of 10 asymptomatic patients but not by CD4+ T cells from 10 of 10 symptomatic patients (P < 0.0001; analysis of variance posttest). Inversely, CD4+ T cells from symptomatic patients preferentially recognized gB661-675 (P < 0.0001). Thus, we identified three previously unrecognized CD4+ CTL peptide epitopes in HSV-1 gB. Among these, gB166-180 and gB666-680 appear to be "asymptomatic" peptide epitopes and therefore should be considered in the design of future herpes vaccines.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000069
- to stream PascalFrancis, to step Curation: 000025
- to stream PascalFrancis, to step Checkpoint: 000069
- to stream Main, to step Merge: 002B45
- to stream Main, to step Curation: 002B19
- to stream Main, to step Exploration: 002B19
- to stream France, to step Extraction: 000181
Links to Exploration step
Pascal:09-0013229Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B</title>
<author><name sortKey="Alami Chentoufi, Aziz" sort="Alami Chentoufi, Aziz" uniqKey="Alami Chentoufi A" first="Aziz" last="Alami Chentoufi">Aziz Alami Chentoufi</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1>
<s2>Irvine, California 92697-4375</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Irvine, California 92697-4375</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Binder, Nicholas R" sort="Binder, Nicholas R" uniqKey="Binder N" first="Nicholas R." last="Binder">Nicholas R. Binder</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1>
<s2>Irvine, California 92697-4375</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Irvine, California 92697-4375</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Berka, Noureddine" sort="Berka, Noureddine" uniqKey="Berka N" first="Noureddine" last="Berka">Noureddine Berka</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Tissue Typing Laboratory</s1>
<s2>Calgary, Alberta T2L2K8</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Tissue Typing Laboratory</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Durand, Guillaume" sort="Durand, Guillaume" uniqKey="Durand G" first="Guillaume" last="Durand">Guillaume Durand</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>CEA, iBiTecS, Service d'Ingenierie Moléculaire des Protéines (SIMOPRO)</s1>
<s2>Gif Sur Yvette 91191</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nguyen, Alex" sort="Nguyen, Alex" uniqKey="Nguyen A" first="Alex" last="Nguyen">Alex Nguyen</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1>
<s2>Irvine, California 92697-4375</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Irvine, California 92697-4375</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bettahi, Ilham" sort="Bettahi, Ilham" uniqKey="Bettahi I" first="Ilham" last="Bettahi">Ilham Bettahi</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1>
<s2>Irvine, California 92697-4375</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Irvine, California 92697-4375</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Maillere, Bernard" sort="Maillere, Bernard" uniqKey="Maillere B" first="Bernard" last="Maillere">Bernard Maillere</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>CEA, iBiTecS, Service d'Ingenierie Moléculaire des Protéines (SIMOPRO)</s1>
<s2>Gif Sur Yvette 91191</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Benmohamed, Lbachir" sort="Benmohamed, Lbachir" uniqKey="Benmohamed L" first="Lbachir" last="Benmohamed">Lbachir Benmohamed</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1>
<s2>Irvine, California 92697-4375</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Irvine, California 92697-4375</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Center for Immunology, University of California Irvine</s1>
<s2>Irvine, California 92697-1450</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Irvine, California 92697-1450</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">09-0013229</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 09-0013229 INIST</idno>
<idno type="RBID">Pascal:09-0013229</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000069</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000025</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000069</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000069</idno>
<idno type="wicri:doubleKey">0022-538X:2008:Alami Chentoufi A:asymptomatic:human:cd</idno>
<idno type="wicri:Area/Main/Merge">002B45</idno>
<idno type="wicri:Area/Main/Curation">002B19</idno>
<idno type="wicri:Area/Main/Exploration">002B19</idno>
<idno type="wicri:Area/France/Extraction">000181</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B</title>
<author><name sortKey="Alami Chentoufi, Aziz" sort="Alami Chentoufi, Aziz" uniqKey="Alami Chentoufi A" first="Aziz" last="Alami Chentoufi">Aziz Alami Chentoufi</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1>
<s2>Irvine, California 92697-4375</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Irvine, California 92697-4375</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Binder, Nicholas R" sort="Binder, Nicholas R" uniqKey="Binder N" first="Nicholas R." last="Binder">Nicholas R. Binder</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1>
<s2>Irvine, California 92697-4375</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Irvine, California 92697-4375</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Berka, Noureddine" sort="Berka, Noureddine" uniqKey="Berka N" first="Noureddine" last="Berka">Noureddine Berka</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Tissue Typing Laboratory</s1>
<s2>Calgary, Alberta T2L2K8</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Tissue Typing Laboratory</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Durand, Guillaume" sort="Durand, Guillaume" uniqKey="Durand G" first="Guillaume" last="Durand">Guillaume Durand</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>CEA, iBiTecS, Service d'Ingenierie Moléculaire des Protéines (SIMOPRO)</s1>
<s2>Gif Sur Yvette 91191</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nguyen, Alex" sort="Nguyen, Alex" uniqKey="Nguyen A" first="Alex" last="Nguyen">Alex Nguyen</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1>
<s2>Irvine, California 92697-4375</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Irvine, California 92697-4375</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bettahi, Ilham" sort="Bettahi, Ilham" uniqKey="Bettahi I" first="Ilham" last="Bettahi">Ilham Bettahi</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1>
<s2>Irvine, California 92697-4375</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Irvine, California 92697-4375</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Maillere, Bernard" sort="Maillere, Bernard" uniqKey="Maillere B" first="Bernard" last="Maillere">Bernard Maillere</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>CEA, iBiTecS, Service d'Ingenierie Moléculaire des Protéines (SIMOPRO)</s1>
<s2>Gif Sur Yvette 91191</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Benmohamed, Lbachir" sort="Benmohamed, Lbachir" uniqKey="Benmohamed L" first="Lbachir" last="Benmohamed">Lbachir Benmohamed</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Cellular and Molecular Immunology, The Gavin S. Herbert Eye Institute, University of California Irvine, School of Medicine</s1>
<s2>Irvine, California 92697-4375</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Irvine, California 92697-4375</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Center for Immunology, University of California Irvine</s1>
<s2>Irvine, California 92697-1450</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Irvine, California 92697-1450</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of virology</title>
<title level="j" type="abbreviated">J. virol.</title>
<idno type="ISSN">0022-538X</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of virology</title>
<title level="j" type="abbreviated">J. virol.</title>
<idno type="ISSN">0022-538X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antigenic determinant</term>
<term>Asymptomatic</term>
<term>Cytotoxic T lymphocyte</term>
<term>Glycoprotein</term>
<term>Herpesvirus hominis</term>
<term>Human</term>
<term>T-Lymphocyte</term>
<term>Virology</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Homme</term>
<term>Herpesvirus hominis</term>
<term>Asymptomatique</term>
<term>Lymphocyte T</term>
<term>Lymphocyte T cytotoxique</term>
<term>Déterminant antigénique</term>
<term>Glycoprotéine</term>
<term>Virologie</term>
<term>Antigène CD4</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The identification of "asymptomatic" (i.e., protective) epitopes recognized by T cells from herpes simplex virus (HSV)-seropositive healthy individuals is a prerequisite for an effective vaccine. Using the PepScan epitope mapping strategy, a library of 179 potential peptide epitopes (15-mers overlapping by 10 amino acids) was identified from HSV type 1 (HSV-1) glycoprotein B (gB), an antigen that induces protective immunity in both animal models and humans. Eighteen groups (G1 to G18) of 10 adjacent peptides each were first screened for T-cell antigenicity in 38 HSV-1-seropositive but HSV-2-seronegative individuals. Individual peptides within the two immunodominant groups (i.e., G4 and G14) were further screened with T cells from HLA-DR-genotyped and clinically defined symptomatic (n = 10) and asymptomatic (n = 10) HSV-1-seropositive healthy individuals. Peptides gB<sub>161-175</sub>
and gB<sub>166-180</sub>
within G4 and gB<sub>661-675</sub>
within G14 recalled the strongest HLA-DR-dependent CD4<sup>+</sup>
T-cell proliferation and gamma interferon production. gB<sub>166-180,</sub>
gB<sub>661-675</sub>
, and gB<sub>666-680</sub>
elicited ex vivo CD4<sup>+</sup>
cytotoxic T cells (CTLs) that lysed autologous HSV-1- and vaccinia virus (expressing gB)-infected lymphoblastoid cell lines. Interestingly, gB<sub>166-180</sub>
and gB<sub>666-680</sub>
peptide epitopes were strongly recognized by CD4<sup>+</sup>
T cells from 10 of 10 asymptomatic patients but not by CD4<sup>+</sup>
T cells from 10 of 10 symptomatic patients (P < 0.0001; analysis of variance posttest). Inversely, CD4<sup>+</sup>
T cells from symptomatic patients preferentially recognized gB<sub>661-675</sub>
(P < 0.0001). Thus, we identified three previously unrecognized CD4<sup>+</sup>
CTL peptide epitopes in HSV-1 gB. Among these, gB<sub>166-180</sub>
and gB<sub>666-680</sub>
appear to be "asymptomatic" peptide epitopes and therefore should be considered in the design of future herpes vaccines.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
<li>France</li>
<li>États-Unis</li>
</country>
<region><li>Île-de-France</li>
</region>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Alami Chentoufi, Aziz" sort="Alami Chentoufi, Aziz" uniqKey="Alami Chentoufi A" first="Aziz" last="Alami Chentoufi">Aziz Alami Chentoufi</name>
</noRegion>
<name sortKey="Benmohamed, Lbachir" sort="Benmohamed, Lbachir" uniqKey="Benmohamed L" first="Lbachir" last="Benmohamed">Lbachir Benmohamed</name>
<name sortKey="Benmohamed, Lbachir" sort="Benmohamed, Lbachir" uniqKey="Benmohamed L" first="Lbachir" last="Benmohamed">Lbachir Benmohamed</name>
<name sortKey="Bettahi, Ilham" sort="Bettahi, Ilham" uniqKey="Bettahi I" first="Ilham" last="Bettahi">Ilham Bettahi</name>
<name sortKey="Binder, Nicholas R" sort="Binder, Nicholas R" uniqKey="Binder N" first="Nicholas R." last="Binder">Nicholas R. Binder</name>
<name sortKey="Nguyen, Alex" sort="Nguyen, Alex" uniqKey="Nguyen A" first="Alex" last="Nguyen">Alex Nguyen</name>
</country>
<country name="Canada"><noRegion><name sortKey="Berka, Noureddine" sort="Berka, Noureddine" uniqKey="Berka N" first="Noureddine" last="Berka">Noureddine Berka</name>
</noRegion>
</country>
<country name="France"><region name="Île-de-France"><name sortKey="Durand, Guillaume" sort="Durand, Guillaume" uniqKey="Durand G" first="Guillaume" last="Durand">Guillaume Durand</name>
</region>
<name sortKey="Maillere, Bernard" sort="Maillere, Bernard" uniqKey="Maillere B" first="Bernard" last="Maillere">Bernard Maillere</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000181 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000181 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= France |étape= Analysis |type= RBID |clé= Pascal:09-0013229 |texte= Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B }}
This area was generated with Dilib version V0.6.33. |